Zoekresultaten - 9 results

Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.

knowledge of human papillomavirus (HPV), its relationship to cervical cancer, and HPV and cervical cancer prevention, and (d) investigating correlates of HPV knowledge and screening compliance. MATERIALS AND ...

Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.

a cervical sample taken by their general practitioner. The cost-effectiveness of this additional strategy will depend on its capacity to recruit nonscreened women and in particular those at increased risk of ...

The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.

and 2011 without evidence of a period effect. CONCLUSIONS: The Polish organised cervical screening programme is only partially adherent to evidence-based EuG. Its implementation has not influenced the ...

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

a low risk of CIN3 + after a negative APTIMA test over a longer period is awaited to inform us about its utility in cervical cancer screening at 5-year or longer intervals Health Topics:  Cancer Cancer ...

Are 20 human papillomavirus types causing cervical cancer?

98.7% of all HPV-positive cervical cancers. From recently updated meta-analyses, it was shown that HPV68, HPV26, HPV66, HPV67, HPV73 and HPV82 were significantly more common in cancer cases than in women ...

HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

/ E7 mRNA and p16INK4a). If it was not possible to abstract the required information directly from the paper, we contacted the authors. We did a meta-analysis to produce pooled prevalence estimates ...

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

re-infection, against cervical cancer and its precursors (high-grade CIN (grade 2 or grade 3), adenocarcinoma in situ) in women previously not exposed to HPV infection (negative at enrolment for both HPV DNA and ...

Cytological screening for cervical cancer in the province of Limburg, Belgium.

Abstract: Cervical cancer screening in Belgium is mainly opportunistic with periodic attempts to organize it according to the European guidelines. In the province of Limburg (north-east Belgium), a cervical ...

Screening for cervical cancer in Belgium" in Description of the national situation of cervical cancer screening in the member states of the European Union

European Union. There is yet high diversity in the status of cervical screening, and rapid changes expected to occur in the situation in many countries. It is important to underline differences in the health ...

QR code

QR code for this page URL